June 6, 2014

Upsher-Smith Laboratories on Wednesday announced that it has received final approval from the Food and Drug Administration for its new drug application for Vogelxo (testosterone) gel for topical use CIII.

December 26, 2013

Sales of personal lubricants were down 5.2% to $207.5 million in sales for the 52 weeks ended Oct. 6, according to IRI across total U.S. multi-outlets.

December 6, 2013

The Food and Drug Administration has approved a treatment for a sexual deformity that affects men.

July 9, 2013

Sylk USA introduced its new Sylk personal lubricant, a water-based lubricant made from New Zealand kiwi vine extract.

April 1, 2013

The Food and Drug Administration has approved a new contraceptive therapy made by Teva Pharmaceutical Industries, Teva said Monday.

February 26, 2013

The Food and Drug Administration has approved a drug for postmenopausal women who experience pain during sex.

November 28, 2012

Regional life sciences association Biocom has introduced a new eco-friendly alternative to sanitary napkins and tampons. Enter FemmyCycle, a product from member FemCap.

November 7, 2012

Absorption Pharmaceuticals recently launched Promescent, an over-the-counter lidocaine-based spray indicated for premature ejaculation.

August 13, 2012

The Food and Drug Administration is reviewing a regulatory application from Teva for a contraceptive drug, the company said Monday.

June 29, 2011

A topical drug made by Eli Lilly restored testosterone to normal levels in men with abnormally low testosterone, according to results of a late-stage clinical trial.

June 27, 2011

Feminine hygiene brand Summer's Eve recently launched a video that encourages dialogue about the female anatomy.

June 1, 2011

The Food and Drug Administration is investigating a possible link between a class of birth control pills and a higher risk of blood clots in the women taking them, the agency said.

March 4, 2011

Freeman Beauty's Feeling Beautiful line is expanding with three new products.

December 23, 2010

The Food and Drug Administration has approved the first and only low-dose oral contraceptive to combine 0.8-mg norethindrone and 0.025-mg ethinyl estradiol in a chewable form, with four 75-mg ferrous fumarate (iron) placebo tablets, Watson Pharmaceuticals has announced.

November 14, 2010

The makers of Zestra held a symposium on Oct. 28 at New York’s Penn Club...

October 27, 2010

Sexual dysfunction often is conceived as a male phenomenon, but it frequently affects women as...

October 21, 2010

The Food and Drug Administration has approved a new contraceptive from Warner Chilcott, the drug...

May 6, 2010

The Food and Drug Administration has approved a new oral contraceptive made by Bayer, the...